BAX and cancer: CUR is recognized for its ability to induce Bax/Bcl2‐involved apoptosis in cancer cells,16, 42 as evidenced by the elevated levels of Bax, Bax/Bcl2 and cleaved caspase‐3 in both CT26 and HCT116 cells treated with CUR at the 4‐h time point in our study (Figure 3A,C).